Patents (1436 Stem Cell Patents)

Class: Type (195)

Order by:
<< | < | 3 4 5 6 7 8 9 10 11 | > | >>


Human adult astrocytes, their preparation and uses thereof

Patent Number: 6943016

This invention teaches how to obtain a population of astrocytes that is free of microglial cells from a fresh biopsy specimen. The invention has one independent claim covering the process of explanting a tissue that contains both astrocytes and microglial cells, culturing the cells in vitro under conditions that selectively promote adherence of the astrocytes to the culture vessel, and after...

Inventors: Ridet, Jean-Luc (Lausanne, CH); Mallet, Jacques (Paris, FR)
Assignee: Aventis Pharma S.A. (Antony, FR)
Date of First Priority Issue: Saturday May 1st, 1999

Adipose-derived stem cells and lattices

Patent Number: 7,470,537

The therapeutic benefits of adipose derived stem cells have been demonstrated in animal trials and are currently undergoing several clinical trials.  Although patents have been issued on methods of isolating fat derived stem cells, such as 7,390,484 held by Cytori, or 7,078,232 held by Artecel covering adipose stem cells...

Inventors: Hedrick; Marc H. (Encino, CA), Katz; Adam J. (Charlottesville, VA), Llull; Ramon (Mallorca, Balearic Isles, ES), Futrell; J. William (Pittsburgh, PA), Benhaim; Prosper (Encino, CA), Lorenz; Hermann Peter (Belmont, CA), Zhu; Min (Los Angeles, CA)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Wednesday March 10th, 1999

Adipose-derived stem cells and lattices

Patent Number: 6777231

This is one of the founding patents covering work performed by Cytori, formerly Macropore. The patent covers an adipose derived stem cell that can diffentiate into bone, cartilage cell, nerve, or muscle cells.

Inventors: Katz, Adam J. (Charlottesville, VA); Llull, Ramon (Mallorca, ES); Futrell, William J. (Pittsburgh, PA); Hedrick, Marc H. (Encino, CA); Benhaim, Prosper (Los Angeles, CA); Lorenz, Hermann Peter (Los Angeles, CA); Zhu, Min (Los Angeles, CA)
Assignee: The Regents of the University of California (Oakland, CA)
Date of First Priority Issue: Wednesday March 10th, 1999

Compositions of enriched central nervous system stem cell and progenitor cell populations

Patent Number: 7,153,686

This patent covers a "Neurosphere Initiating Cell" isolated by its expression of the marker CD133. CD133 is expressed in a variety of stem cells and was recently shown to be found on cancer stem cells as well. Essentially, neurospheres are aggregates of neural cells that are grown in tissue culture...

Inventors: Uchida; Nobuko (Palo Alto, CA), Buck; David W. (Santa Clara, CA), Weissman; Irving (Redwood City, CA)
Assignee: Stemcells California, Inc. (Palo Alto, CA)
Date of First Priority Issue: Friday February 12th, 1999

Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations

Patent Number: 7,217,565

This patent covers the isolation of neural stem cells, primarily from human fetal origin. These stem cells are purified by 2 steps. First the fetal cells are bound to the antibody 8G1 and then they are further purified for expression of AC133 and 5E12. This patent is similar to several others from the same family such as Inventors: Buck; David W. (Eugene, OR), Uchida; Nobuko (Palo Alto, CA), Weissman; Irving (Redwood City, CA)

Assignee: StemCells California, Inc. (Palo Alto, CA)
Date of First Priority Issue: Friday February 12th, 1999

Double nuclear transfer method and results thereof

Patent Number: 7,531,715

The area of cloning is of great interest in terms of therapeutics development, not only from the perspective of generating de novo stem cell populations, but also the possibility of making transgenic animals for practical purposes such as food or protein production.  Accordingly, numerous patents have been issued on all sorts of variations of the cloning process, as well as...

Inventors: Campbell; Keith H. S. (Leicestershire, GB)
Assignee: PPL Therapeutics (Scotland) (Edinburgh, GB)
Date of First Priority Issue: Wednesday January 13th, 1999

Transgenic circulating endothelial cells

Patent Number: 6852537

This patent covers the expansion of endothelial cells by growing on collagen-1 coated plates in the combination of various growth factors such as FGF, VEGF, and IGF. Additionally, numerous culture conditions for endothelial expansion are disclosed. The abstract of the patent discribes the use of endothelial cells for gene therapy, but...

Inventors: Hebbel, Robert P. (North Oaks, MN); Lin, Yi (St. Paul, MN); Lollar, John S. (Decatur, GA)
Assignee: Regents of the University of Minnesota Emory University (Atlanta, GA)
Date of First Priority Issue: Tuesday November 24th, 1998

Embryonic stem cells

Patent Number: 6875607

Despite its appealing title, the claims of this patent appear only to cover the alteration of differentiation of embryonic stem cells, in part through providing the use of feeder cell layers.

Inventors: Reubinoff, Benjamin Eithan (Elsternwick, AU); Pera, Martin Frederick (Prahran, AU); Fong, Chui-Yee (Singapore, SG); Trounson, Alan Osborne (Asburton, AU); Bongso, Ariffeen (Singapore, SG)
Assignee: ES Cell International Pte Ltd (Singapore, SG)
Date of First Priority Issue: Monday November 9th, 1998

Myeloid precursor cell useful for gene therapy and for modulation of immune responses

Patent Number: 7,198,909

Myeloid progenitor cells are known to be responsible for producing polymorphonuclear leukocytes as well as monocytes in the blood. Besides their well-known function in the classical hematopoietic system, myeloid progenitor cells ahve been reported by various groups to have immune modulatory function, specifically, the ability to inhibit immune responses through factors such as Inventors: Ron; Yacov (East Brunswick, NJ), Dougherty; Joseph P. (Hampton, NJ), Chen; Chiann-Chyi (East Brunswick, NJ)

Assignee: University of Medicine & Dentistry of New Jersey (New Brunswick, NJ)
Date of First Priority Issue: Saturday October 31st, 1998

Trophoblast cell preparations

Patent Number: 6630349

This patent provides trophoblast cell lines that are of murine origin. Since the trophoblast is similar to cancer cells in terms of immune suppression and metastizing ability, this patent is useful for the generation of a xenogeneic cancer vaccine, similar to XenoVax. The fact that trophoblast stem cells are provided is useful since this can be a good off the shelf starting population for...

Inventors: Rossant, Janet (Toronto, CA); Tanaka, Satoshi (Tokyo, JP); Kunath, Tilo (Toronto, CA)
Assignee: Mount Sinai Hospital (Toronto, CA)
Date of First Priority Issue: Wednesday September 23rd, 1998

Order by:
<< | < | 3 4 5 6 7 8 9 10 11 | > | >>


Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent